Form 8-K - Current report:
SEC Accession No. 0001937653-25-000012
Filing Date
2025-03-05
Accepted
2025-03-05 16:08:20
Documents
15
Period of Report
2025-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zyme-20250305.htm   iXBRL 8-K 39346
2 EX-99.1 ex991q42024_earningsxrelea.htm EX-99.1 105423
6 zw_logo.jpg GRAPHIC 13528
  Complete submission text file 0001937653-25-000012.txt   302328

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zyme-20250305.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zyme-20250305_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zyme-20250305_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT zyme-20250305_htm.xml XML 2815
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 25710987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)